Articolul precedent |
Articolul urmator |
337 9 |
Ultima descărcare din IBN: 2024-03-18 09:38 |
SM ISO690:2012 CHETRUŞ, Olga. Myocardial metabolic changes under the influence of meldonium treatment. In: Cercetarea în biomedicină și sănătate: calitate, excelență și performanță, Ed. 1, 20-22 octombrie 2021, Chişinău. Chișinău, Republica Moldova: 2021, p. 139. ISBN 978-9975-82-223-7 (PDF).. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Cercetarea în biomedicină și sănătate: calitate, excelență și performanță 2021 | ||||||
Conferința "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță" 1, Chişinău, Moldova, 20-22 octombrie 2021 | ||||||
|
||||||
Pag. 139-139 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. Currently, there is a process of “rejuvenation” of the ICC, occupying important positions in society, which is why the given disease needs to be considered as one with important social value. Objective of the study. Randomized clinical trial analysis of the efficacy and harmlessness of inclusion in standardized pharmacotherapy of mildronate in patients with stable angina pectoris. Material and Methods. An open randomized clinical trial was performed that included 160 patients with CPI (117 men and 43 women) with a mean age of 59.26 ± 0.74 years. 142 patients had stable angina pectoris from different functional classes, and 21 - unstable angina pectoris. The control group included 30 practically healthy people. The observation period was 6 weeks. Results. There was a significant decrease in serum concentrations of organospecific myocardial enzymes - CFK-MB and LDH1, which speaks of the reduction of the ”leakage” of enzymes from the cytoplasm of cells following the stabilization of cardiomyocyte membranes. A significant decrease in the plasma concentration of pyruvate was detected, and in the mitochondria - the activation of PDH, indicating the stimulation of the oxidative decarboxylation process of pyruvate. Significant catalase and insignificant superoxide dismutase activation was also found in mitochondria. Conclusion. In patients with myocardial ischemia mildronate activates glycolysis, oxidative phosphorylation and oxidative decarboxylation, stabilizes the cardiomyocyte membrane, reduces the degree of hypoxia, restoring the level of ATP and adequate energy intake to the myocardium. |
||||||
Cuvinte-cheie ischemic heart disease, cytoprotection, Mildronate, cardiopatie ischemică, citoprotecție, mildronat |
||||||
|